| Autor: |
Abraham, Linu Jacob, Rudresha, A. H., Saldanha, Smitha Carol, Koppaka, Deepak, Kuntegowdanahalli, Lakshmaiah Chinnagiriyappa, Dasappa, Lokanatha, Kiran, Pretesh Rohan |
| Předmět: |
|
| Zdroj: |
Clinical Cancer Investigation Journal; Mar/Apr2016, Vol. 5 Issue 2, p200-202, 3p |
| Abstrakt: |
Gemcitabine is a cytotoxic drug with superior toxicity profile and widely used in the management of various solid malignancies. The common side effects associated with gemcitabine are myelosuppression, diarrhea, and flu-like symptoms. Cardiac side effects due to gemcitabine are very rare. We present a case of an elderly female aged 69 years, diagnosed to have metastatic carcinoma gallbladder, and without any cardiac risk factors, who developed supraventricular tachycardia 3 days after gemcitabine infusion. We emphasize the need for careful and routine cardiac monitoring in an elderly patient who develops symptoms of tachyarrhythmia when on gemcitabine therapy. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
